BackBioNexus Gene Lab Overview

BioNexus Gene Lab Common Stock

Track BioNexus Gene Lab's common stock ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$20.17M

Peer average / median

Loading

BioNexus Gene Lab Common Stock History

Loading

BioNexus Gene Lab vs. peers: Common Stock Comparison

Loading

BioNexus Gene Lab Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

BioNexus Gene Lab (BGLC) FAQ

BioNexus Gene Lab's common stock stands at $20M as of March 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

BioNexus Gene Lab reported $20M in common stock versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how BioNexus Gene Lab's common stock evolved across reporting periods, while the comparison chart places BGLC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.